Even if you regain some weight, you may still weigh considerably less than you did when you started treatment
Key Considerations Compounded semaglutide is not equivalent to FDA-approved semaglutide products Safety, efficacy, and quality may vary among compounded formulations Use requires medical supervision and ongoing monitoring Cost, availability, and formulation differ depending on the pharmacy and prescription Patients should discuss FDA-approved options, compounded alternatives, potential risks, and expected outcomes with their healthcare provider before starting treatment
Source: Arrone, et al New England J of Medicine May 11, 2025 Implications for employers: Employers looking to cover GLP-1 medications for weight loss should review formulary options to best balance cost and clinical outcomes
If ignored, this tingling can progress into numbness, balance issues, and coordination problems
Analysis of the available research reports that tirzepatide administered at 15mg/weekly may result in a hazard ratio (HR) of 0.8 for the incidence of cardiovascular events